1. Home
  2. TSBX vs POLA Comparison

TSBX vs POLA Comparison

Compare TSBX & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSBX
  • POLA
  • Stock Information
  • Founded
  • TSBX 2015
  • POLA 1979
  • Country
  • TSBX United States
  • POLA United States
  • Employees
  • TSBX N/A
  • POLA N/A
  • Industry
  • TSBX
  • POLA Industrial Machinery/Components
  • Sector
  • TSBX
  • POLA Miscellaneous
  • Exchange
  • TSBX Nasdaq
  • POLA Nasdaq
  • Market Cap
  • TSBX 10.2M
  • POLA 8.3M
  • IPO Year
  • TSBX 2023
  • POLA 2016
  • Fundamental
  • Price
  • TSBX $0.43
  • POLA $3.17
  • Analyst Decision
  • TSBX Buy
  • POLA
  • Analyst Count
  • TSBX 3
  • POLA 0
  • Target Price
  • TSBX $4.75
  • POLA N/A
  • AVG Volume (30 Days)
  • TSBX 158.9K
  • POLA 75.1K
  • Earning Date
  • TSBX 03-20-2025
  • POLA 11-14-2024
  • Dividend Yield
  • TSBX N/A
  • POLA N/A
  • EPS Growth
  • TSBX N/A
  • POLA N/A
  • EPS
  • TSBX N/A
  • POLA N/A
  • Revenue
  • TSBX N/A
  • POLA $14,953,000.00
  • Revenue This Year
  • TSBX N/A
  • POLA $6.72
  • Revenue Next Year
  • TSBX N/A
  • POLA N/A
  • P/E Ratio
  • TSBX N/A
  • POLA N/A
  • Revenue Growth
  • TSBX N/A
  • POLA N/A
  • 52 Week Low
  • TSBX $0.40
  • POLA $2.24
  • 52 Week High
  • TSBX $5.75
  • POLA $4.90
  • Technical
  • Relative Strength Index (RSI)
  • TSBX 39.13
  • POLA 50.84
  • Support Level
  • TSBX $0.41
  • POLA $3.07
  • Resistance Level
  • TSBX $0.62
  • POLA $3.34
  • Average True Range (ATR)
  • TSBX 0.06
  • POLA 0.31
  • MACD
  • TSBX -0.01
  • POLA -0.01
  • Stochastic Oscillator
  • TSBX 8.96
  • POLA 45.05

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications primarily in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, Back-up DC generators, hybrid power systems, Li-Ion battery systems, and Marine DC generators. The Companie's geographical presence is in the United States, Canada, Mexico, South Pacific Islands, Japan, Europe and Middle East and Other Asia Pacific countries.

Share on Social Networks: